 |
FDA-TRACK is an agency-wide performance management system that monitors over 100 FDA program offices through key performance measures and projects. These measures are reported monthly and updated quarterly on the website.
What's New with FDA-TRACK
February 2012 Performance Data Updates
New performance data is available for the dashboards below.
Cross Agency
- January 9, 2012: FDA-TRACK Advisory Committees Quarterly Briefing Summary – Click for information on a new FDA Advisory Committee.
- FDA-TRACK Advisory Committees Dashboard – Visit the dashboard for complete FY11 data.
- January 12, 2012: FDA-TRACK Freedom of Information ACT (FOIA) Quarterly Briefing Summary
- FDA-TRACK FOIA Dashboard
- FDA-TRACK Health Care Reform (ACA) Dashboard
- FDA-TRACK Medical Countermeasures Initiative (MCMi) Dashboard – Includes new program measures for the Center for Biologics Evaluation and Research (CBER) to track the number of scientific manuscripts and external presentations facilitating development of medical countermeasures (MCMs). Includes a new key project for the Center for Drug Evaluation and Research (CDER) to track animal models of pregnancy to address MCMs for influenza and chemical, biological, radiological and nuclear threats in pregnant women. Also includes a new key project to track the progress of the MCMi Public Regulatory Science Symposium.
National Center for Toxicological Research (NCTR)
- FDA-TRACK NCTR Administrative and Coordination Offices Dashboard – Visit the dashboard for complete FY11 data.
- FDA-TRACK NCTR Research Divisions Dashboard – Visit the dashboard for complete FY11 data.
Office of Operations
- FDA-TRACK Office of Operations Dashboard – Office of Management launched a new Key Project. eDepart is a new IT application designed to facilitate the departure and transfer process of employees and non-employees to improve coordination between physical and network security, accountable property control, financial controls, Ethics, OIP and other administrative coordination.
Office of Special Medical Programs (OSMP)
- January 9, 2012: FDA-TRACK OSMP Quarterly Briefing Summary – Click for complete FY11 performance information on combination products, good clinical practice, orphan products, and pediatric therapeutics.
- FDA-TRACK Office of Special Medical Programs Dashboard – Visit the dashboard for complete FY11 data.
Office of the Commissioner (OC)
- FDA-TRACK OC Office of the Chief Scientist (OCS) Dashboard – Office of Counterterrorism and Emerging Threats (OCET) completed its key project, “Implement MCM Initiative (MCMi),” and Office of Regulatory Science and Innovation (ORSI) completed its key project, “Modernize Toxicology Testing.”
March 2012 Upcoming Performance Data Updates
The below listed programs are expected to publish performance data updates in March 2012. Updates are posted to each dashboard approximately 30 business days after each quarterly briefing with FDA senior leadership.
- Center for Biologics Evaluation and Research (CBER)
- Center for Devices and Radiological Health (CDRH)
- Center for Veterinary Medicine (CVM)
General Program Updates
- Quarterly Briefing Summaries – Visit this page for public summaries of accomplishments discussed at each FDA-TRACK briefing. We post summaries approximately 30 business days after each quarterly briefing, along with updated performance measures and results. This page includes a new summary for Advisory Committees, FOIA, and OSMP.
- Completed Key Projects – Visit this page to read about completed key projects to date. New additions include NCTR, OCS, and OSMP.
- Didn’t find what you were looking for? Please email us at FDATRACK@fda.hhs.gov to suggest performance measures or key projects.
| This email was sent to clotito+biotechdash@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
No comments:
Post a Comment